A detailed history of B&L Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, B&L Asset Management LLC holds 5,098 shares of BMY stock, worth $298,233. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,098
Holding current value
$298,233
% of portfolio
0.17%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $202,186 - $263,821
5,098 New
5,098 $264 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track B&L Asset Management LLC Portfolio

Follow B&L Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B&L Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on B&L Asset Management LLC with notifications on news.